Total Payments
$366,840
2024 Payments
$467.61
Companies
16
Transactions
312
Medicare Patients
831
Medicare Billing
$85,526
Payment Breakdown by Category
Other$270,891 (73.8%)
Consulting$75,274 (20.5%)
Travel$12,583 (3.4%)
Food & Beverage$5,063 (1.4%)
Gifts$2,859 (0.8%)
Education$171.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $270,891 | 105 | 73.8% |
| Consulting Fee | $75,274 | 26 | 20.5% |
| Travel and Lodging | $12,583 | 43 | 3.4% |
| Food and Beverage | $5,063 | 131 | 1.4% |
| Gift | $2,859 | 4 | 0.8% |
| Education | $171.00 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $151,071 | 104 | $0 (2021) |
| EMD Serono, Inc. | $61,325 | 68 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $53,523 | 24 | $0 (2018) |
| Genentech USA, Inc. | $36,635 | 21 | $0 (2023) |
| Celgene Corporation | $25,270 | 41 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $18,050 | 10 | $0 (2023) |
| Biogen, Inc. | $17,097 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,618 | 16 | $0 (2024) |
| Genentech, Inc. | $92.88 | 3 | $0 (2018) |
| Mallinckrodt Hospital Products Inc. | $30.15 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $467.61 | 11 | Celgene Corporation ($323.57) |
| 2023 | $3,394 | 24 | E.R. Squibb & Sons, L.L.C. ($2,715) |
| 2022 | $13,994 | 10 | E.R. Squibb & Sons, L.L.C. ($13,785) |
| 2021 | $17,059 | 14 | Biogen, Inc. ($7,910) |
| 2020 | $48,645 | 46 | Celgene Corporation ($14,947) |
| 2019 | $84,939 | 66 | GENZYME CORPORATION ($45,597) |
| 2018 | $96,917 | 63 | GENZYME CORPORATION ($48,803) |
| 2017 | $101,425 | 78 | GENZYME CORPORATION ($45,295) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Neuroscience | ||||||
| 05/01/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| 04/30/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Immunology | ||||||
| 04/17/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: Neurology | ||||||
| 04/16/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $6.34 | General |
| Category: Neuroscience | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: Neurology | ||||||
| 02/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Neuroscience | ||||||
| 02/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.84 | General |
| Category: Neuroscience | ||||||
| 02/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.23 | General |
| Category: Neuroscience | ||||||
| 01/30/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/19/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,618.00 | General |
| Category: Neuroscience | ||||||
| 11/29/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $96.96 | General |
| Category: Neuroscience | ||||||
| 11/28/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: Neurology | ||||||
| 11/15/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Neurology | ||||||
| 11/14/2023 | Celgene Corporation | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 11/08/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $2.76 | General |
| Category: Neuroscience | ||||||
| 10/24/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Rare Disease | ||||||
| 10/17/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $1.46 | General |
| Category: Neuroscience | ||||||
| 09/29/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Neurology | ||||||
| 09/06/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.43 | General |
| Category: Neuroscience | ||||||
| 08/22/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $3.67 | General |
| Category: Neuroscience | ||||||
| 08/22/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.59 | General |
| Category: Neuroscience | ||||||
| 08/22/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.18 | General |
| Category: Neuroscience | ||||||
| 08/02/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $124.42 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 142 | 179 | $35,890 | $15,841 |
| 2022 | 7 | 184 | 218 | $41,452 | $18,774 |
| 2021 | 7 | 218 | 258 | $52,670 | $22,612 |
| 2020 | 6 | 287 | 337 | $67,898 | $28,299 |
Total Patients
831
Total Services
992
Medicare Billing
$85,526
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 76 | $12,920 | $5,710 | 44.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 32 | $10,094 | $3,906 | 38.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 24 | $5,664 | $2,957 | 52.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 26 | $4,524 | $2,439 | 53.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 21 | 21 | $2,688 | $829.73 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 101 | $17,170 | $7,839 | 45.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 31 | $10,199 | $4,606 | 45.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 20 | $4,720 | $2,520 | 53.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 16 | $3,664 | $1,632 | 44.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 22 | 23 | $2,944 | $970.52 | 33.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 16 | $1,952 | $877.28 | 44.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 11 | $803.00 | $329.02 | 41.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 88 | 120 | $20,400 | $8,441 | 41.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 55 | 55 | $18,095 | $8,341 | 46.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 19 | $4,351 | $1,907 | 43.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 17 | $2,958 | $1,384 | 46.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 15 | $3,540 | $1,336 | 37.7% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 17 | 18 | $2,304 | $776.90 | 33.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 12 | 14 | $1,022 | $426.02 | 41.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 72 | 72 | $23,688 | $10,768 | 45.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 91 | 121 | $20,570 | $8,315 | 40.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 24 | 40 | $6,960 | $3,203 | 46.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 24 | 24 | $5,664 | $2,186 | 38.6% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 33 | 36 | $4,608 | $1,577 | 34.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 32 | $3,648 | $1,169 | 32.1% |
About Dr. Jayne Ward, D.O
Dr. Jayne Ward, D.O is a Neurology healthcare provider based in East Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700999166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jayne Ward, D.O has received a total of $366,840 in payments from pharmaceutical and medical device companies, with $467.61 received in 2024. These payments were reported across 312 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($270,891).
As a Medicare-enrolled provider, Ward has provided services to 831 Medicare beneficiaries, totaling 992 services with total Medicare billing of $85,526. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location East Lansing, MI
- Active Since 08/17/2006
- Last Updated 06/23/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1700999166
Products in Payments
- AUBAGIO (Drug) $104,917
- COPAXONE (Drug) $53,523
- LEMTRADA (Drug) $46,153
- Mavenclad (Biological) $24,848
- Rebif (Biological) $24,833
- ZEPOSIA (Drug) $24,592
- OCREVUS (Biological) $21,892
- Non-Covered Product (Drug) $14,743
- Mavenclad (Drug) $11,411
- Ozanimod (Drug) $7,174
- VUMERITY (Drug) $6,702
- TYSABRI (Biological) $4,489
- PLEGRIDY (Biological) $4,320
- GILENYA (Drug) $3,184
- KESIMPTA (Drug) $386.30
- Rituxan (Biological) $76.00
- MAYZENT (Drug) $47.33
- ACTHAR (Biological) $30.15
- SOLIRIS (Biological) $23.00
- DUOPA (Drug) $22.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in East Lansing
Dr. Mounzer Yassin-Kassab, M.d, M.D
Neurology — Payments: $386,102
Neurology $386,102
Dr. Amit Sachdev, M.d., Ms, M.D., MS
Neurology — Payments: $292,376
Neurology $292,376
Dr. Tariq Gheith, M.d, M.D
Neurology — Payments: $218,666
Neurology $218,666
Dr. Larry Charleston, M.d, M.D
Neurology — Payments: $211,437
Neurology $211,437
Dr. Anmar Razak, M.d, M.D
Neurology — Payments: $146,635
Neurology $146,635
Dr. John Goudreau, D.o, D.O
Neurology — Payments: $95,463
Neurology $95,463